FindTrial
Sign In

Assessing the Benefits of Palmitoylethanolamide and Acetyl Carnitine for Shoulder Pain Relief: A Randomized Controlled Trial

Effect of combination of PEA and acetyl carnitine as an adjunct therapy for periarthritis shoulder. a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098050
Enrollment
60
Registered
2025-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M248- Other specific joint derangements,not elsewhere classified

Interventions

Intervention1: Initiation of a nutraceutical combination of PEA and L acetyl carnitine: once a day for one month Control Intervention1: placebo: one month

Sponsors

S Parthasarathy ST multi hospitals private limited kumbakonam India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age 30 - 70 years diagnosed to have periarthritis shoulder VAS score of 4 or above

Exclusion criteria

Exclusion criteria: Previous shoulder surgery or invasive procedures within the last 6 months Active inflammatory or autoimmune diseases Pregnancy or lactation Allergy to study medications Use of corticosteroids

Design outcomes

Primary

MeasureTime frame
pain relief in terms of reduction of NRS pain scoresTimepoint: initiation of the drug or placebo to one month—

Secondary

MeasureTime frame
mobility shoulder by way of assessment of Constant Murley ScoreTimepoint: initiation to 1 month—

Countries

India

Contacts

Public ContactS Parthasarathy

ST multispeciality hospitals nageswaran north, kumbakonam 612002 India

anaespartha@gmail.com09344304042

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026